Dematiaceous fungi

Clinical Mycology

Volumn , Issue , 2009, Pages 329-354

  Sutton, Deanna A ^a   Rinaldi, Michael G ^a   Sanche, Stephen E ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78049385351     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-5680-5.00014-1     Document Type: Chapter

References (171)

1. Pappagianis D., Ajello L. Dematiaceous - a mycologic misnomer?. J Med Vet Mycol 1994, 32:319.
2. Kimura M., McGinnis M.R. Fontana-Masson-stained tissue from culture-proven mycoses. Arch Pathol Lab Med 1998, 122:1107.
3. de Hoog G.S., Guarro J., Gené J., Figueras M.J. Atlas of Clinical Fungi 2000, Centraalbureau voor Schimmelcultures, The Netherlands. 2nd edn.
4. Sutton D.A., Fothergill A.W., Rinaldi M.G. Guide to Clinically Significant Fungi 1998, Williams and Wilkins, Baltimore.
5. Schell W.A., Salkin I.F., McGinnis M.R. Bipolaris, Scedosporium, Sporothrix, and other dematiaceous fungi. Manual of Clinical Microbiology 2003, 1820. ASM Press, Washington, DC. 8th edn. P.R. Murray, E.J. Baron, J.H. Jorgensen, M.A. Pfaller, R.H. Yolken (Eds.).
6. Schell W.A. Dematiaceous hyphomycetes. Pathogenic Fungi in Humans and Animals 2003, 565. Marcel Dekker, New York. D.H. Howard (Ed.).
7. Mostert L., Groenewald J.Z., Summerbell R.C., et al. Species of Phaeoacremonium associated with human infections and environmental reservoirs in infected woody plants. J Clin Microbiol 2005, 43:1752.
8. Al-Mohsen Z., Sutton D.A., Sigler L., et al. Acrophialophora fusispora brain abscess in a child with acute lymphoblastic leukemia: review of cases and taxonomy. J Clin Microbiol 2000, 38:4569.
9. Seeliger H.P. Infections of humans by opportunistic molds - their identification and nomenclature of their disease. Mykosen 1983, 26:587.
10. Revankar S.G., Sutton D.A., Rinaldi M.G. Primary central nervous system phaeohyphomycosis: a review of 101 cases. Clin Infect Dis 2004, 38:206.
11. Espinel-Ingroff A., Goldson P.R., McGinnis M.R., Kerkering T.M. Evaluation of proteolytic activity to differentiate some dematiaceous fungi. J Clin Microbiol 1988, 26:301.
12. Kaufman L., Standard P.G. Specific and rapid identification of medically important fungi by exoantigen detection. Annu Rev Microbiol 1987, 41:209.
13. Pasarell L., McGinnis M.R., Standard P.G. Differentiation of medically important isolates of Bipolaris and Exserohilum with exoantigens. J Clin Microbiol 1990, 28:1655.
14. Uijthof J.M.J. Relationships within the black yeast genus Exophiala based on ITS1 sequences. Mycol Res 1996, 100:1265.
15. de Hoog G.S. Evolution of black yeasts: possible adaptation to the human host. Antonie van Leeuwenhoek 1993, 63:105.
16. de Hoog G.S., Vicente V., Caligiorne R.B., et al. Species diversity and polymorphism in the Exophiala spinifera clade containing opportunistic black yeast-like fungi. J Clin Microbiol 2003, 41:4767.
17. de Hoog G.S., Zeng J.S., Harrak M.J., Sutton D.A. Exophiala xenobiotica sp. nov., an opportunistic black yeast inhabiting environments rich in hydrocarbons. Antonie van Leeuwenhoek 2006, 90:257.
18. Zeng J.S., Sutton D.A., Fothergill A.W., et al. Spectrum of clinically relevant Exophiala species in the U.S.A. J Clin Microbiol 2007, 45:3713.
19. Hiruma M., Kawada A., Ohata T., et al. Systemic phaeohyphomycosis caused by Exophiala dermatitidis. Mycoses 1993, 36:1.
20. Horré R., Schaal K.P., Siekmeier R., et al. Isolation of fungi, expecially Exophiala dermatitidis, in patient suffering from cystic fibrosis. A prospective study. Respiration 2004, 71:360.
21. Uijthof J.M.J., de Hoog G.S., de Cock A.W.A.M., et al. Pathogenicity of strains of the black yeast Exophiala (Wangiella) dermatitidis: an evaluation based on polymerase chain reaction. Mycoses 1994, 37:235.
22. Bossler A.D., Richter S.S., Chavez A.J., et al. Exophiala oligosperma causing olecranon bursitis. J Clin Microbiol 2003, 41:4779.
23. Jotsinkasa V., Nielsen H.S., Conant N.F. Phialophora dermatitidis, its morphology and biology. Sabouraudia 1970, 8:98.
24. Tintelnot K., de Hoog G.S., Thomas E., et al. Cerebral phaeohyphomycosis caused by an Exophiala species. Mycoses 1991, 34:239.
25. Matos T., Haase G., Gerrits van den Ende A.H.G., de Hoog G.S. Molecular diversity of oligotrophic and neurotropic members of the black yeast genus Exophiala, with accent on E. dermatitidis. Antonie van Leeuwenhoek 2003, 83:293.
26. Sudduth E.J., Crumbley A.J., Farrar W.E. Phaeohyphomycosis due to Exophiala species: clinical spectrum of disease in humans. Clin Infect Dis 1992, 15:639.
27. Padhye A.A., Hampton A.A., Hampton M.T., et al. Chromoblastomycosis caused by Exophiala spinifera. Clin Infect Dis 1996, 22:331.
28. Vitale R.G., de Hoog G.S. Molecular diversity, new species and antifungal susceptibilities in the Exophiala spinifera clade. Med Mycol 2002, 40:545.
29. Nucci M., Akiti T., Barreiros G., et al. Nosocomial outbreak of Exophiala jeanselmei fungemia associated with contamination of hospital water. Clin Infect Dis 2002, 34:1475.
30. Engemann J., Kaye K., Cox G., et al. Exophiala infection from contaminated injectable steroids prepared by a compounding pharmacy-United States. MMWR 2002, 51:1109.
31. Porteous N.B., Grooters A.M., Redding S.W., et al. Identification of Exophiala mesophila isolated from treated dental unit waterlines. J Clin Microbiol 2003, 41:3885.
32. de Hoog G.S., Gerrits van den Ende A.H.G. Nutritional pattern and eco-physiology of Hortaea werneckii, agent of human tinea nigra. Antonie van Leeuwenhoek 1992, 62:321.
33. Yurlova N.A., Mokrousov I.V., de Hoog G.S. Intraspecific variability and exopolysaccharide production in Aureobasidium pullulans. Antonie van Leeuwenhoek 1995, 68:57.
34. Yurlova N.A., de Hoog G.S., Gerrits van den Ende A.H.G. Taxonomy of Aureobasidium and allied genera. Stud Mycol 1999, 43:63-69.
35. de Hoog G.S., Yurlova N.A. Conidiogenesis, nutritional physiology and taxonomy of Aureobasidium and Hormonema. Antonie van Leeuwenhoek 1994, 65:41.
36. Coldiron B.M., Wiley E.L., Rinaldi M.G. Cutaneous phaeohyphomycosis caused by a rare fungal pathogen, Hormonema dematioides: successful treatment with ketoconazole. J Am Acad Dermatol 1990, 23:363.
37. Shin J.H., Lee S.K., Suh S.P., et al. Fatal Hormonema dematioides peritonitis in a patient on continuous ambulatory peritoneal dialysis: criteria for organism identification and review of other known fungal etiologic agents. J Clin Microbiol 1998, 36:2157.
38. Bartolome B., Valks R., Fraga J., et al. Cutaneous alternariosis due to Alternaria chlamydospora after bone marrow transplantation. Acta Derm Vener 1999, 79:277.
39. Nulens E., De Laere E., Vandevelde H., et al. Alternaria infectoria phaeohyphomycosis in a renal transplant patient. Med Mycol 2006, 44:379.
40. Robertshaw H., Higgins E. Cutaneous infection with Alternaria tenuissima in an immunocompromised patient. Br J Dermatol 2005, 153:1047.
41. Ferrer C., Monter J., Alío Jl, et al. Rapid molecular diagnosis of post-traumatic keratitis and endophthalmitis caused by Alternaria infectoria. J Clin MIcrobiol 2003, 2003:3358.
42. Badenoch P.R., Halliday C.L., Ellis D.H., et al. Ulocladium atrum kerratitis. J Clin Microbiol 2006, 44:1190.
43. McGinnis M.R., Rinaldi M.G., Winn R.E. Emerging agents of phaeohyphomycosis: pathogenic species of Bipolaris and Exserohilum. J Clin Microbiol 1986, 24:250.
44. Fothergill A.W. Identification of dematiaceous fungi and their role in human disease. Clin Infect Dis 1996, 22(suppl):S179.
45. Carter E., Boudreaux C. Fatal cerebral phaeohyphomycosis due to Curvularia lunata in an immunocompetent patient. J Clin Microbiol 2004, 42:5419.
46. Pathengay A., Shah G.Y., Das T., Sharma S. Curvularia lunata endophthalmitis presenting with a posterior capsular plaque. Indian J Ophthalmol 2006, 54:65.
47. Kainer M.A., Keshavarz H., Jensen B.T., et al. Saline-filled breast implant contamination with Curvularia species among women who underwent cosmetic breast augmentation. J Infect Dis 2005, 192:170.
48. Pimentel J.D., Mahadevan K., Woodgyer A., et al. Peritonitis due to Curvularia inaequalis in an elderly patient undergoing peritoneal dialysis and a review of six cases of peritonitis associated with other Curvularia spp. J Clin Microbiol 2005, 43:4288.
49. Rinaldi M.G., Phillips P., Schwartz J.G., et al. Human Curvularia infections: report of five cases and review of the literature. Diagn Microbiol Infect Dis 1987, 6:27.
50. Surash S., Tyagi A., de Hoog G.S., et al. Cerebral phaeohyphomycosis caused by Fonsecaea monophora. Med Mycol 2005, 43:465.
51. de Hoog G.S., Attili-Angelis D., Vincente V.A., et al. Molecular ecology and pathogenic potential of Fonsecaea species. Med Mycol 2004, 42:405.
52. del Palacio H.A., Moore M.K., Campbell C.K., et al. Infection of the central nervous system by Rhinocladiella atrovirens in a patient with acquired immunodeficiency syndrome. J Med Vet Mycol 1989, 27:127.
53. Schell W.A., Pasarell L., Salkin I.F., McGinnis M.R. Bipolaris, Exophiala, Scedosporium, Sporothrix, and other dematiaceous fungi. Manual of Clinical Microbiology 1995, 825. ASM Press, Washington, DC. 6th edn. P.R. Murray, E.J. Baron, M.A. Pfaller, F.C. Tenover, R.H. Yolken (Eds.).
54. Campbell C.K., Al-Hedaithy S.S.A. Phaeohyphomycosis of the brain caused by Ramichloridium mackenzii sp. nov. in Middle Eastern countries. J Med Vet Mycol 1993, 31:325.
55. Sutton D.A., Slifkin M., Yakulis R., Rinaldi M.G. U.S. case report of cerebral phaeohyphomycosis caused by Ramichloridium obovoideum (R. mackenziei): criteria for identification, therapy, and review of other known dematiaceous neurotropic taxa. J Clin Microbiol 1998, 36:708.
56. Sutton D.A., Rinaldi M.G., Kielhofner M. First U.S. report of subcutaneous phaeohyphomycosis caused by Veronaea botryosa in a heart transplant recipient and review of the literature. J Clin Microbiol 2004, 42:2843.
57. Rinaldi M.G. Phaeohyphomycosis. Dermatol Clin 1996, 14:147.
58. de Hoog G.S., Gueho E., Masclaux F., et al. Nutritional physiology and taxonomy of human-pathogenic Cladosporium-Xylohypha species. J Med Vet Mycol 1995, 33:339.
59. Masclaux F., Gueho E., de Hoog G.S., Christen R. Phylogenetic relationships of human-pathogenic Cladosporium (Xylohypha) species inferred from partial LS rRNA sequences. J Med Vet Mycol 1995, 33:327.
60. Levin T.P., Baty D.E., Fekete T., et al. Cladophialophora bantiana brain abscess in a solid-organ transplant recipient: case report and review of the literature. J Clin Microbiol 2004, 42:4374.
61. McGinnis M.R., Lemon S.M., Walker S.M., et al. Fatal cerebritis caused by a new species of Cladophialophora. Stud Mycol 1999, 43:166.
62. Howard S.J., Walker S.L., Andrew M., et al. Sub-cutaneous phaeohyphomycosis caused by Cladophialophora devriesii in a United Kingdom resident. Med Mycol 2006, 44:553.
63. Arthur S., Steed L.L., Apple D.J., et al. Scedosporium prolificans keratouveitis in association with a contact lens retained intraocularly over a long term. J Clin Microbiol 2001, 39:4579.
64. Baddley J.W., Moser S.A., Sutton D.A., et al. Microascus cinereus (anamorph Scopulariopsis) brain abscess in a bone marrow transplant recipient. J Clin Microbiol 2000, 38:395.
65. Vijaykrishna D., Mostert L., Jeewon R., et al. Pleurostomophora, an anamorph of Pleurostoma (Calosphaeriales), a new anamorph genus morphologically similar to Phialophora. Stud Mycol 2004, 50:387.
66. Pitrak D.L., Koneman E.W., Estupinan R.C., Jackson J. Phialophora richardsiae in humans. Rev Infect Dis 1988, 10:1195.
67. Mostert L., Groenewald J.Z., Summerbell R.C., et al. Taxonomy and pathology of Togninia (Diaporthales) and its Phaeoacremonium anamorphs. Stud Mycol 2006, 54:1.
68. Crous P.W., Gams W., Wingfield M.J., van Wyk P.S. Phaeoacremonium gen. nov. associated with wilt and decline diseases of woody hosts and human infections. Mycologia 1996, 88:786.
69. Guarro J., Silvestre A.M., Verkley G., et al. Limitations of DNA sequencing for diagnosis of a mixed infection by two fungi, Phaeoacremonium venezuelense and a Plectophomella sp., in a transplant recipient. J Clin Microbiol 2006, 44:4279.
70. Baddley J.W., Mostert L., Summerbell C., Moser S.A. Phaeoacremonium parasiticum infections confirmed by β-tubulin sequence analysis of case isolates. J Clin Microbiol 2006, 44:2207.
71. Marques S.A., Camargo R.M.P., Summerbell R.C., et al. Subcutaneous phaeohyphomycosis caused by Phaeoacremonium parasiticum in a renal transplant recipient. Med Mycol 2006, 44:671.
72. Guarro J., Nucci M., Akiti T., et al. Phialemonium fungemia: two documented nosocomial cases. J Clin Microbiol 1999, 37:2493.
73. Gavin P.J., Sutton D.A., Katz B.Z. Fatal endocarditis in a neonate caused by the dematiaceous fungus Phialemonium obovatum: case report and review of the literature. J Clin Microbiol 2002, 40:2207.
74. Scott R.S., Sutton D.A., Jagirdar J. Lung infection due to opportunistic fungus, Phialemonium obovatum, in a bone marrow transplant recipient: an emerging infection with fungemia and Crohn disease-like involvement of the gastrointestinal tract. Ann Diagn Pathol 2005, 9:227.
75. Proia L.A., Hayden M.K., Kammeyer P.L., et al. Phialemonium, an emerging mould pathogen causing four cases of hemodialysis-associated endovascular infection. Clin Infect Dis 2004, 38:373.
76. Strahilevitz J., Rahav G., Schroers H.J., et al. An outbreak of Phialemonium infective endocarditis linked to intracavernous penile injections for the treatment of impotence. Clin Infect Dis 2005, 40:781.
77. Weinberger M., Mahrshak I., Keller N., et al. Isolated engogenous endophthalmitis due to a sporodochial-forming Phialemonium curvatum acquired through intracavernous autoinjections. Med Mycol 2006, 44:253.
78. Dan M., Yossepowitch O., Hendel D., et al. Phialemoniun curvatum arthritis of the knee following intra-articular injection of a corticosteroid. Med Mycol 2006, 44:571.
79. Scott I.U., Cruz-Villegas V., Flynn H.W., Miller D. Delayed-onset, bleb-associated endophthalmitis caused by Lecythophora mutabilis. Am J Ophthalmol 2004, 137:583.
80. Marriott D.J.E., Wong K.H., Aznar E., et al. Scytalidium dimidiatum and Lecythophora hoffmannii: unusual causes of fungal infections in a patient with AIDS. J Clin Microbiol 1997, 35:2949.
81. Pierach D.A., Gulmen G., Jeelani Dhar G., Kiser J.C. Phialophora mutabilis endocarditis. Ann Intern Med 1993, 79:900.
82. Boggild A.K., Poutanen S.M., Mohan S., Ostrowski M.A. Disseminated phaeohyphomycosis due to Ochroconis gallopavum in the setting of advanced HIV infection. Med Mycol 2006, 44:777.
83. Fukushima N., Mannen K., Okamoto S., et al. Disseminated Ochroconis gallopavum infection in a chronic lymphocytic leukemia: a case report and review of the literature on hematological malignancies. Intern Med 2005, 44:879.
84. Wang T.K., Chiu W., Chim S., et al. Disseminated Ochroconis gallopavum infection in a renal transplant recipient: the first reported case and a review of the literature. Clin Nephrol 2003, 60:415.
85. Bourbeau P., McGough D.A., Fraser H., et al. Fatal disseminated infection caused by Myceliophthora thermophila, a new agent of mycosis: case history and laboratory characteristics. J Clin Microbiol 1992, 30:3019.
86. Farina C., Gamba A., Tambini R., et al. Fatal aortic Myceliophthora thermophila infection in a patient affected by cystic medical necrosis. Med Mycol 1998, 36:113.
87. Destino L., Sutton D.A., Helon A.L., et al. Severe osteomyelitis caused by Myceliophthora thermorphila after a pitchfork injury. Ann Clin Microbiol Antimicrob 2006, 5:21.
88. Sigler L., Summerbell R.C., Poole L., et al. Invasive Nattrassia mangiferae infections: case report, literature review, and therapeutic and taxonomic appraisal. J Clin Microbiol 1997, 35:433.
89. Roeijmans H.J., de Hoog G.S., Tan C.S., Figge M.J. Molecular taxonomy and GC/MS of metabolites of Scytalidium hyalinum and Nattrassia mangiferae. J Med Vet Mycol 1997, 35:181.
90. Boerema G.H., de Gruyter J., Noordeloos M.E., Hamers M.E.C. Phoma Identification Manual. Differentiation of Specific and Infra-specific Taxa in Culture 2004, CABI Publishing, Oxfordshire, UK.
91. Padhye A.A., Gutekunst R.W., Smith D.J., Punithalingam E. Maxillary sinusitis caused by Pleurophomopsis lignicola. J Clin Microbiol 1997, 35:2136.
92. Pendle S., Weeks K., Priest M., et al. Phaeohyphomycotic soft tissue infections caused by the coelomycetous fungus Microsphaeropsis arundinis. J Clin Microbiol 2004, 42:5315.
93. Shah C.V., Jones D.B., Holz E.R. Microsphaeropsis olivacea keratitis and consecutive ophthalmitis. Am J Ophthalmol 2001, 131:142.
94. Verkley G.J.M., da Silva M., Wicklow D.T., Crous P.W. Paraconiothyrium, a new genus to accommodate the mycoparasite Coniothyrium minitans, anamorph of Paraphaeosphaeria, and four new species. Stud Mycol 2004, 50(2):323.
95. Sutton D.A. Coelomycetous fungi in human disease. A review: clinical entities, pathogenesis, identification and therapy. Rev Iberoam Micol 1999, 16:171.
96. Yu J., Yang S., Zhao Y., Li R. A case of subcutaneous phaeohyphomycosis caused by Chaetomium globosum and the sequences analysis of C. globosum. Med Mycol 2006, 44:541.
97. Barron M.A., Sutton D.A., Veve R., et al. Invasive mycotic infections caused by Chaetomium perludicum, a new agent of cerebral phaeohyphomycosis. J Clin Microbiol 2003, 41:5302.
98. Krisher K.K., Holdridge N.B., Mustafa M.M., et al. Disseminated Microascus cirrosus infection in a pediatric bone marrow transplant recipient. J Clin Microbiol 1995, 33:735.
99. Mohammedi I., Piens M.A., Audigier-Valette C., et al. Fatal Microascus trigonosporus (anamorph Scopulariopsis) pneumonia in a bone marrow transplant recipient. Eur J Clin Microbiol Infect Dis 2004, 23:215.
100. Desnos-Ollivier M., Gretagne S., Dromer F., et al. Molecular identification of black-grain mycetoma agents. J Clin Microbiol 2006, 44:3517.
101. Elgart G.W. Chromoblastomycosis. Dermatol Clin 1996, 14:77.
102. Medlar E.M. A cutaneous infection caused by a new fungus, Phialophora verrucosa, with a study of the fungus. J Med Res 1915, 32:507.
103. Odds F.C., Arai T., DiSalvo A.F., et al. Nomenclature of fungal diseases: a report and recommendations from a sub-committee of the International Society for Human and Animal Mycology (ISHAM). J Med Vet Mycol 1992, 30:1.
104. Minotto R., Bernardi C.D., Mallmann L.F., et al. Chromoblastomycosis: a review of 100 cases in the state of Rio Grande do Sul, Brazil. J Am Acad Dermatol 2001, 44:585.
105. Esterre P., Andriantsimahavandy A., Ramarcel E.R., et al. Forty years of chromoblastomycosis in Madagascar: a review. Am J Trop Med Hyg 1996, 55:45.
106. Carrion A.L. Chromoblastomycosis. Ann N Y Acad Sci 1950, 50:1255.
107. Szaniszlo P.J., Hsieh P.H., Marlowe J.D. Induction and ultrastructure of the multicellular (sclerotic) morphology in Phialophora dermatitidis. Mycologia 1976, 68:117.
108. de Hoog G.S., Attili-Angelis D., Vicente V.A., et al. Molecular ecology and pathogenic potential of Fonsecaea species. Med Mycol 2004, 42:405.
109. Fader R.C., McGinnis M.R. Infections caused by dematiaceous fungi: chromoblastomycosis and phaeohyphomycosis. Infect Dis Clin North Am 1988, 2:925.
110. Castro L.G., Pimentel E.R., Lacaz C.S. Treatment of chromomycosis by cryosurgery with liquid nitrogen: 1 years' experience. Int J Dermatol 2003, 42:408.
111. Bonifaz A., Paredes-Solis V., Saul A. Treating chromoblastomycosis with systemic antifungals. Expert Opin Pharmacother 2004, 5:247.
112. Borelli D. A clinical trial of itraconazole in the treatment of deep mycoses and leishmaniasis. Rev Infect Dis 1987, 9(suppl 1):S57.
113. Bonifaz A., Martinez-Soto E., Carrasco-Gerard E., et al. Treatment of chromoblastomycosis with itraconazole, cryosurgery, and a combination of both. Int J Dermatol 1997, 36:542.
114. Ungpakorn R., Reangchainam S. Pulse itraconazole 400 mg daily in the treatment of chromoblastomycosis. Clin Exp Dermatol 2006, 31:245.
115. Gupta A.K., Taborda P.R., Sanzovo A.D. Alternate week and combination itraconazole and terbinafine therapy for chromoblastomycosis caused by Fonsecaea pedrosoi in Brazil. Med Mycol 2002, 40:529.
116. Restrepo A., Gonzalez A., Gomez I., et al. Treatment of chromoblastomycosis with itraconazole. Ann N Y Acad Sci 1988, 544:504.
117. Bonifaz A., Saul A., Paredes-Solis V., et al. Treatment of chromoblastomycosis with terbinafine: experience with four cases. J Dermatolog Treat 2005, 16:47.
118. Xibao Z., Changxing L., Quan L., et al. Treatment of chromoblastomycosis with terbinafine: a report of four cases. J Dermatolog Treat 2005, 16:121.
119. Esterre P., Inzan C.K., Ramarcel E.R., et al. Treatment of chromomycosis with terbinafine: preliminary results of an open pilot study. Br J Dermatol 1996, 134(suppl 46):33.
120. Negroni R., Tobon A., Bustamante B., et al. Posaconazole treatment of refractory eumycetoma and chromoblastomycosis. Rev Inst Med Trop Sao Paulo 2005, 47:339.
121. McGinnis M.R. Mycetoma. Dermatol Clin 1996, 14:97.
122. Mahgoub E.S. Mycetoma. Semin Dermatol 1985, 4:230.
123. Rippon J.W. Mycetoma. Medical Mycology: The Pathogenic Fungi and the Pathogenic Actinomycetes 1988, WB Saunders, Philadelphia.
124. Rinaldi M.G., Lamazor E.A., Roeser E.H., et al. Mycetoma or pseudomycetoma? A distinctive mycosis cause by dermatophytes. Mycopathologia 1983, 81:41.
125. Queiroz-Telles F., McGinnis M.R., Salkin I., et al. Subcutaneous mycoses. Infect Dis Clin North Am 2003, 17:59.
126. Desnos-Ollivier M., Bretagne S., Dromer F., et al. Molecular identification of black-grain mycetoma agents. J Clin Microbiol 2006, 44:3517.
127. Ahmed A.O., van Leeuwen W., Fahal A., et al. Mycetoma caused by Madurella mycetomatis: a neglected infectious burden. Lancet Infect Dis 2004, 4:566.
128. Welsh O., Salinas M.C., Rodriguez M.A. Treatment of eumycetoma and actinomycetoma. Curr Top Med Mycol 1995, 6:47.
129. Mahgoub E.S., Gumaa S.A. Ketoconazole in the treatment of eumycetoma due to Madurella mycetomii. Trans R Soc Trop Med Hyg 1984, 78:376.
130. Poncio Mendes R., Negroni R., Bonifaz A., et al. New aspects of some endemic mycoses. Med Mycol 2000, 38(suppl 1):237.
131. Hay R.J., Mahgoub E.S., Leon G., et al. Mycetoma. J Med Vet Mycol 1992, 30(suppl 1):41.
132. N'Diaye B., Dieng M.T., Perez A., et al. Clinical efficacy and safety of oral terbinafine in fungal mycetoma. Int J Dermatol 2006, 45:154.
133. Loulergue P., Hot A., Dannaoui E., et al. Successful treatment of black-grain mycetoma with voriconazole. Am J Trop Med Hyg 2006, 75:1106.
134. Ajello L., Georg L.K., Steigbigel R.T., et al. A case of phaeohyphomycosis caused by a new species of Phialophora. Mycologia 1974, 66:490.
135. Rippon J.W. Phaeohyphomycosis. Medical Mycology: The Pathogenic Fungi and the Pathogenic Actinomycetes 1988, WB Saunders, Philadelphia.
136. Ajello L. The gamut of human infections caused by dematiaceous fungi. Jpn J Med Mycol 1981, 22:1.
137. McGinnis M.R., Ajello L., Schell W.A. Mycotic diseases. A proposed nomenclature. Int J Dermatol 1985, 24:9.
138. Wood C., Russel-Bell B. Characterization of pigmented fungi by melanin staining. Am J Dermatopathol 1983, 5:77.
139. Rinaldi M.G. Phaeohyphomycosis. Dermatol Clin 1996, 14:147.
140. Matsumoto T., Ajello L., Matsuda T., et al. Developments in hyalohyphomycosis and phaeohyphomycosis. J Med Vet Mycol 1994, 32(suppl 1):329.
141. Revankar S.G. Phaeohyphomycosis. Infect Dis Clin North Am 2006, 20:609.
142. Schwartz R.A. Superficial fungal infections. Lancet 2004, 364:1173.
143. Assaf R.R., Weil M.C. The superficial mycoses. Dermatol Clin 1996, 14:57.
144. Moyer D.G., Keeler C. Note on the culture of black piedra for cosmetic reasons. Arch Dermatol 1964, 89:436.
145. Gip L. Black piedra: the first case treated with terbinafine. Br J Dermatol 1994, 130:26.
146. Hay R.J., Moore M.K. Clinical features of superficial fungal infections caused by Hendersonula toruloidea and Scytalidium hyalinum. Br J Dermatol 1984, 110:677.
147. Boisseau-Garsaud A.M., Desbois N., Guillermin M.L., et al. Onychomycosis due to Exophiala jeanselmei. Dermatology 2002, 204:150.
148. Ziefer A., Connor D.H. Phaeomycotic cyst. A clinicopathologic study of twenty-five patients. Am J Trop Med Hyg 1980, 29:901.
149. Ichinose H. Subcutaneous abscesses due to brown fungi. Human Infection with Fungi, Actinomycetes and Algae 1971, 719. Springer-Verlag, New York. R.D. Baker (Ed.).
150. Sharkey P.K., Graybill J.R., Rinaldi M.G., et al. Itraconazole treatment of phaeohyphomycosis. J Am Acad Dermatol 1990, 23:577.
151. Koga T., Matsuda T., Matsumoto T., et al. Therapeutic approaches to subcutaneous mycoses. Am J Clin Dermatol 2003, 4:537.
152. Clancy C.J., Wingard J.R., Hong Nguyen M. Subcutaneous phaeohyphomycosis in transplant recipients: review of the literature and demonstration of in vitro synergy between antifungal agents. Med Mycol 2000, 38:169.
153. Thomas P.A. Current perspectives on ophthalmic mycoses. Clin Microbiol Rev 2003, 16:730.
154. Wilhelmus K.R. Climatology of dematiaceous fungal keratitis. Am J Ophthalmol 2005, 140:1156.
155. Garg P., Gopinathan U., Choudhary K., et al. Keratomycosis: clinical and microbiologic experience with dematiaceous fungi. Ophthalmology 2000, 107:574.
156. Thiel M.A., Zinkernagel A.S., Burhenne J., et al. Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis. Antimicrob Agents Chemother 2007, 51:239.
157. Ozbek Z., Kang S., Sivalingam J., et al. Voriconazole in the management of Alternaria keratitis. Cornea 2006, 25:242.
158. Schubert M.S. Allergic fungal sinusitis: pathogenesis and management strategies. Drugs 2004, 64:363.
159. deShazo R.D., Chapin K., Swain R.E. Fungal sinusitis. N Engl J Med 1997, 337:254.
160. Millar J.W., Johnston A., Lamb D. Allergic aspergillosis of the maxillary sinuses. Thorax 1981, 36:710.
161. Kuhn F.A., Swain R.J. Allergic fungal sinusitis: diagnosis and treatment. Curr Opin Otolaryngol Head Neck Surg 2003, 11:1.
162. Handley G.H., Visscher D.W., Katzenstein A.A., et al. Bone erosion in allergic fungal sinusitis. Am J Rhinol 1990, 4:149.
163. Revankar S.G., Patterson J.E., Sutton D.A., et al. Disseminated phaeohyphomycosis: review of an emerging mycosis. Clin Infect Dis 2002, 34:467.
164. Odell J.A., Alvarez S., Cvitkovich D.G., et al. Multiple lung abscesses due to Ochroconis gallopavum, a dematiaceous fungus, in a nonimmunocompromised wood pulp worker. Chest 2000, 118:1503.
165. Ziza J.M., Dupont B., Boissonnas A., et al. (Osteoarthritis caused by dematiaceous fungi. Apropos of 3 cases.). Ann Med Interne (Paris) 1985, 136:393.
166. Rossmann S.N., Cernoch P.L., Davis J.R. Dematiaceous fungi are an increasing cause of human disease. Clin Infect Dis 1996, 22:73.
167. Revankar S.G., Sutton D.A., Rinaldi M.G. Primary central nervous system phaeohyphomycosis: a review of 101 cases. Clin Infect Dis 2004, 38:206.
168. Dixon D.M., Walsh T.J., Merz W.G., et al. Infections due to Xylohypha bantiana (Cladosporium trichoides). Rev Infect Dis 1989, 11:515.
169. Dixon D.M., Merz W.G., Elliott H.L., et al. Experimental central nervous system phaeohyphomycosis following intranasal inoculation of Xylohypha bantiana in cortisone-treated mice. Mycopathologia 1987, 100:145.
170. Fica A., Diaz M.C., Luppi M., et al. Unsuccessful treatment with voriconazole of a brain abscess due to Cladophialophora bantiana. Scand J Infect Dis 2003, 35:892.
171. Al-Abdely H.M., Najvar L.K., Bocanegra R., Graybill J.R. Antifungal therapy of experimental cerebral phaeohyphomycosis due to Cladophialophora bantiana. Antimicrob Agents Chemother 2005, 49:1701.